Jordan
Okonkwo
jordan
.
okonkwo
@
email
.
com
|
(512) 555-0147
|
Austin
,
TX
78701
|
PharmCAS
ID
:
12345678
"
I
don
'
t
understand
why
I
need
all
of
these
if
I
'
m
already
taking
the
white
one
."
Mrs
.
Glover
,
seventy
-
three
and
recently
discharged
after
a
congestive
heart
failure
exacerbation
,
held
three
new
prescriptions
in
trembling
hands
alongside
a
Ziploc
bag
of
existing
medications
.
As
a
pharmacy
technician
at
Walgreens
,
I
had
assisted
hundreds
of
patients
,
but
something
about
her
confusion
stopped
me
cold
.
I
sat
with
her
for
twenty
minutes
,
color
-
coding
her
regimen
and
explaining
that
the
"
white
one
"
was
her
maintenance
dose
while
the
new
pills
addressed
her
recent
fluid
overload
.
When
she
smiled
and
said
, "
Now
I
see
why
you
matter
,"
I
under
-
stood
that
the
pharmacist
'
s
role
extends
far
beyond
the
counter
—
it
is
the
final
,
critical
bridge
between
a
prescription
and
a
patient
'
s
wellbeing
.
That
moment
crystallized
my
desire
to
pursue
a
Doctor
of
Pharmacy
de
-
gree
.
I
had
initially
entered
the
healthcare
field
through
a
pre
-
medical
track
,
drawn
by
the
intellectual
challenge
of
diagnosing
disease
.
However
,
working
alongside
pharmacists
revealed
a
different
but
equally
vital
form
of
care
:
one
centered
on
medication
optimization
,
patient
education
,
and
the
long
-
term
management
of
chronic
illness
.
While
physicians
diagnose
,
pharmacists
ensure
that
treatment
actu
-
ally
works
in
the
messy
reality
of
a
patient
'
s
daily
life
.
I
want
to
be
the
clinician
who
catches
that
a
patient
'
s
dizziness
stems
from
a
drug
interaction
,
or
who
adjusts
an
anticoagulation
regimen
based
on
a
recent
dietary
change
.
My
undergraduate
studies
in
Biochemistry
at
the
University
of
Texas
pro
-
vided
the
rigorous
scientific
foundation
necessary
for
pharmacy
.
In
Dr
.
Lian
Wang
'
s
medicinal
chemistry
laboratory
,
I
investigated
the
CYP
2
D
6
metabolism
of
codeine
analogs
,
learning
how
genetic
polymorphisms
can
turn
a
standard
analgesic
into
a
life
-
threatening
overdose
risk
for
ultra
-
rapid
metabolizers
.
This
research
taught
me
that
pharmacy
is
not
simply
the
study
of
what
drugs
do
,
but
why
they
behave
dif
-
ferently
across
diverse
populations
.
I
presented
our
findings
at
the
Texas
Undergraduate
Research
Conference
,
and
the
experience
solidified
my
commit
-
ment
to
evidence
-
based
,
personalized
medicine
.
Beyond
the
laboratory
,
I
sought
direct
clinical
exposure
to
understand
the
pharmacist
'
s
evolving
scope
of
practice
.
During
a
six
-
month
shadowing
experi
-
ence
at
CommUnityCare
Health
Centers
,
an
FQHC
serving
Austin
'
s
underserved
populations
,
I
observed
clinical
pharmacists
managing
anticoagulation
clinics
,
con
-
1 / 2
ducting
comprehensive
medication
reviews
,
and
adjusting
insulin
protocols
under
collaborative
practice
agreements
.
I
watched
a
pharmacist
spend
forty
-
five
min
-
utes
with
a
Spanish
-
speaking
patient
with
Type
2
diabetes
,
using
teach
-
back
methods
to
confirm
understanding
of
insulin
timing
.
The
patient
'
s
A
1
C
had
dropped
from
10.2%
to
7.1%
over
eight
months
—
not
because
of
a
new
prescription
,
but
be
-
cause
a
pharmacist
had
built
trust
,
simplified
the
regimen
,
and
removed
barriers
to
adherence
.
That
is
the
kind
of
incremental
,
transformative
impact
I
want
to
have
.
My
volunteer
work
at
the
Manos
de
Cristo
free
dental
and
medical
clinic
further
exposed
me
to
health
disparities
that
pharmacy
is
uniquely
positioned
to
address
.
Many
of
our
immigrant
patients
arrived
with
polypharmacy
from
multiple
prescribers
and
conflicting
instructions
in
languages
they
couldn
'
t
read
.
I
helped
develop
a
pictorial
medication
guide
for
low
-
literacy
patients
,
translating
complex
directions
into
visual
schedules
.
The
project
reinforced
my
belief
that
pharmacists
are
public
health
practitioners
as
much
as
they
are
clinical
scientists
.
We
do
not
merely
fill
prescriptions
;
we
interpret
them
,
safeguard
against
them
,
and
translate
them
into
behavior
.
I
am
drawn
specifically
to
pharmacy
because
it
occupies
the
intersection
of
molecular
precision
and
human
relationship
.
Unlike
the
episodic
nature
of
acute
care
,
pharmacy
offers
longitudinal
continuity
—
the
chance
to
follow
a
patient
through
years
of
treatment
,
to
catch
the
subtle
drift
before
it
becomes
a
crisis
.
I
am
particularly
interested
in
ambulatory
care
and
the
management
of
cardiovascu
-
lar
and
metabolic
disease
,
where
medication
non
-
adherence
remains
a
leading
cause
of
hospitalization
.
My
goal
is
to
complete
a
PGY
1
pharmacy
practice
resi
-
dency
followed
by
a
PGY
2
in
ambulatory
care
,
ultimately
working
in
an
interprofes
-
sional
clinic
where
pharmacist
-
led
chronic
disease
management
reduces
costs
and
improves
outcomes
for
vulnerable
populations
.
When
Mrs
.
Glover
returned
two
months
later
with
her
color
-
coded
pillbox
and
a
stable
weight
,
she
asked
if
I
was
"
one
of
the
doctors
now
."
I
told
her
I
was
working
on
it
.
She
replied
, "
Good
.
You
speak
my
language
."
I
knew
she
meant
my
plain
explanations
,
but
I
also
hope
to
literally
serve
bilingual
and
multicultural
com
-
munities
who
too
often
fall
through
the
cracks
of
a
fragmented
system
.
A
Doctor
of
Pharmacy
degree
is
the
essential
next
step
in
becoming
the
clinician
who
en
-
sures
that
no
patient
leaves
the
pharmacy
window
confused
,
overwhelmed
,
or
at
risk
.
Every
prescription
represents
a
person
.
I
am
ready
to
stand
at
that
intersec
-
tion
of
science
and
service
,
one
patient
at
a
time
.
2 / 2